A Science and Technology Blog
India approved Covishield with an interval of four-six weeks between two doses despite the MHRA approving AstraZeneca with a 4-12 weeks gap and JCVI approving a 12-week prime-boost interval. What…
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.
